Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Analog 23 is a promising compound for prostate cancer treatment.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Targeting EGFR may help reduce hair loss from chemotherapy.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Dutasteride and finasteride affect different cell types differently.